Dthera Sciences – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/18 Q3

ended 06/30/18 Q2

ended 03/31/18 Q1

ended 12/31/17 FY 2017

ended 09/30/17 Q3

Prospectuses and Registrations Filter

Initial registration of new securities

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Ownership

No filings in this category.

News Filter

Material Definitive Agreement

Appoints Dr. Amir Kalali to Board of Directors Press Release | 10/30/2018

Announces Reverse Split

Promissory Note Purchase Agreement

Receives FDA Breakthrough Device Designation for Its Alzheimer’s Focused Development-Stage Product “Dthr-Alz”

Proxies

No filings in this category.

Other Filter

SEC STAFF ACTION

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC